Literature DB >> 20616595

Liver functional reserve estimation: state of the art and relevance to local treatments.

Fotini Manizate1, Spiros P Hiotis, Daniel Labow, Sasan Roayaie, Myron Schwartz.   

Abstract

More than 90% of cases of hepatocellular carcinoma develop as a consequence of underlying liver disease (most commonly viral hepatitis), often resulting in impaired liver function. In such cases, transplantation is an appealing alternative as it can potentially treat both the malignancy and the underlying disease. When a transplant is not readily available due to organ scarcity, borderline cases must be considered for resection. The function of the underlying liver can be assessed by the Child-Pugh score or by quantitative tests such as indocyanine green clearance, lidocaine metabolism, and arterial body ketone ratio; liver biopsy pathology scoring and the platelet count can serve as indicators of fibrosis and portal hypertension. Another important factor to be considered is the risk of tumor recurrence, either because of unrecognized metastasis or due to de novo tumor formation. Both factors must be considered in weighing resection against nonsurgical alternatives. Preoperative portal vein embolization is a strategy that can evoke 'regeneration' in anticipation of surgery, serving as a 'stress test' of the liver's regenerative capacity. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20616595     DOI: 10.1159/000315241

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  11 in total

Review 1.  Hagen-Poiseuille's law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  World J Hepatol       Date:  2015-01-27

2.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

3.  A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.

Authors:  Daniel Truhn; Christiane K Kuhl; Alexander Ciritsis; Alexandra Barabasch; Nils A Kraemer
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

4.  Shear wave elastography results correlate with liver fibrosis histology and liver function reserve.

Authors:  Yan-Hong Feng; Xiang-Dong Hu; Lin Zhai; Ji-Bin Liu; Lan-Yan Qiu; Yuan Zu; Si Liang; Yu Gui; Lin-Xue Qian
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

5.  Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.

Authors:  Vladimir Beljanski; Clayton S Lewis; Charles D Smith
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

6.  Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.

Authors:  Michael Haimerl; Mona Schlabeck; Niklas Verloh; Florian Zeman; Claudia Fellner; Dominik Nickel; Ana Paula Barreiros; Martin Loss; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2015-07-18       Impact factor: 5.315

Review 7.  Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

8.  Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Yukio Nakamura; Shigenori Ota; Thomas T Hui; Koichi Hirata
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.

Authors:  Mario Uccello; Giulia Malaguarnera; Elisa M Pelligra; Antonio Biondi; Francesco Basile; Massimo Motta
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

10.  Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.

Authors:  H Kuroki; H Hayashi; S Nakagawa; K Sakamoto; T Higashi; H Nitta; D Hashimoto; A Chikamoto; T Beppu; H Baba
Journal:  Br J Surg       Date:  2015-04-13       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.